glp-1 news 2025 november ISPOR 2025: Exploring reasons for discontinuation 2025 dominates for GLP-1 trial
Description
Let's break it down
The group highlighted four studies some of which were published in its affiliated Journal of Clinical Oncology
Studies show that people taking GLP-1 medications have lower rates of heart attacks and strokes
PBMs will attempt to keep some of this manufacturer rebate money without passing it on to plan sponsors to boost profits
OH, I WOULD MAKE REED TAKE THE TRASH OUT EVERY TIME
